HB 7003 — OGSR/Alzheimer’s Disease Research Grant Advisory Board
by Oversight, Transparency and Public Management Subcommittee and Rep. Pigman (SB 7002 by Health Policy Committee)
This summary is provided for information only and does not represent the opinion of any Senator, Senate Officer, or Senate Office.
Prepared by: Health Policy Committee (HP)
The bill amends s. 381.82(3)(d), F.S., to save from repeal the public records exemptions for information related to the Alzheimer’s Disease Research Grant Advisory Board’s (board) receipt and review of research grant applications. The documents received, and those generated by the board during the review process, except final recommendations, are designated as confidential and exempt but may be disclosed with the written consent of the person to whom the information pertains, or the person’s legally authorized representative, or by court order upon a showing of good cause.
Section 381.82(3)(d), F.S., also exempts from the public meetings laws those portions of the board’s meetings at which the grant applications are discussed.
The exemptions are subject to the Open Government Sunset Review Act and will stand repealed on October 2, 2019, unless reviewed and reenacted by the Legislature.
If approved by the Governor, these provisions take effect October 1, 2019.
Vote: Senate 40-0; House 110-0